You should contact your GP or diabetes specialist nurse if you experience: Significant skin changes that cause distress or affect your quality of life, as this may impact treatment adherence Skin breakdown, ulceration, or persistent redness in areas of loose skin, which could indicate infection or other complications Consistent weight loss exceeding 1 kg per week for several weeks, which may require dose adjustment or additional nutritional support Signs of nutritional deficiency , such as brittle nails, hair loss, or unusual fatigue, which may accompany inadequate dietary intake Concerns about injection site reactions , including lumps, persistent bruising, or changes in skin texture at injection sites Seek urgent medical attention if you develop: Severe, persistent abdominal pain (possibly radiating to the back), which could indicate pancreatitis Yellowing of the skin/eyes, fever or severe abdominal pain, which might suggest gallbladder problems Persistent vomiting or signs of dehydration Sudden visual changes, especially if you have pre-existing diabetic retinopathy Symptoms of low blood sugar (hypoglycaemia) if you also take insulin or sulfonylureas Your healthcare provider can assess whether your weight loss is occurring at an appropriate rate and ensure you are receiving adequate nutritional support

In addition to B-cells, evidence suggests ocrelizumab, the active agent in Ocrevus Zunovo, may also eliminate a subset of T-cells in people with MS, potentially contributing to its efficacy
Scientists also report that local application of BPC-157 may speed up the healing of surgical wounds in rats
You get a refreshed face each month thanks to the average cell turnover rate of once every 28 days
For context, NICE has issued technology appraisals for semaglutide (Wegovy) for weight management and for tirzepatide (Mounjaro) for weight management, each with specific eligibility criteria based on BMI and the presence of weight-related comorbidities
Weve discussed the relative merits of each method in our review of Seed, a competing probiotic brand that also uses AFU